July 12, 2023
Inequities and SDOH | Tea Leaves
  • Health care companies pursuing mergers would have to disclose more information about the transactions under a new Federal Trade Commission (FTC) proposal that could slow health care deal-making. The antitrust agency voted Tuesday to publish a proposed rule that would, in part, require merging parties to disclose any minority investors in an effort to weed out any conflicts of interest; information about prior acquisitions; supplier agreements; subsidies from foreign entities; and workforce data, including information on executives and board members. Additional detail on transactions could give the FTC more ammunition to challenge merger proposals. It could also expedite merger reviews if the expanded notification requirements limit the FTC’s subsequent information requests. (Article here)